KELNOR 1 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Kelnor 1, and when can generic versions of Kelnor 1 launch?
Kelnor 1 is a drug marketed by Watson Labs and is included in one NDA.
The generic ingredient in KELNOR 1 is ethinyl estradiol; ethynodiol diacetate. There are twenty-six drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; ethynodiol diacetate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for KELNOR 1?
- What are the global sales for KELNOR 1?
- What is Average Wholesale Price for KELNOR 1?
Summary for KELNOR 1
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | KELNOR 1 at DailyMed |
US Patents and Regulatory Information for KELNOR 1
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Labs | KELNOR 1/50 | ethinyl estradiol; ethynodiol diacetate | TABLET;ORAL-28 | 072723-001 | Dec 30, 1991 | AB | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
